Skip to content

A study on Panchathaarai kuzhambu(internal medicine) and ottrai thalaivali thylam (external medicine)in the management of ottrai thalaivali(migraine)

A CLINICAL EVALUATION OF SIDDHA HERBAL FORMULATION PANCHATHAARAI KUZHAMBU(INTERNAL MEDICINE) AND OTTRAI THALAIVALI THYLAM(EXTERNAL MEDICINE)IN THE MANAGEMENT OF OTTRAI THALAIVALI(MIGRAINE)AMONG OUT-PATIENTS ATTENDING AYOTHIDOSS PANDITHAR HOSPITAL, NATIONAL INSTITUTE OF SIDDHA

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049693
Enrollment
10
Registered
2023-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

Intervention1: PANCHATHAARAI KUZHAMBU(internal) AND OTTRAI THALAIVALI THYLAM(external): Internal:2 gms to be given orally twice daily with cows milk for 48 days. External:oil bath twice a week for 48

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Five migraine attacks, in the last 3 months each lasting for 4-72 hours and having any two of the following characteristics, a) Headache of unilateral location, b) Pulsating quality, c) Mild to moderate intensity d) Aggravation by routine physical activity. Patient must have at least any one of the following symptoms, a) Often accompanied by nausea (and/or vomiting). b) Sensitivity to light and sound. ? Headache Impact Test total score range 36-59 will be included ? Patient who is willing to participate in the study by signing consent and fulfilling the conditions of Proforma.

Exclusion criteria

Exclusion criteria: Cervical spondylosis Cerebro vascular diseases Trigeminal neuralgia. Traumatic history Psychiatric illness Seizures Alcoholism Pregnancy Sinusitis headaches Ear disorders Eye diseases Diabetes mellitus Hypertension Patient with any other serious systemic diseases.

Design outcomes

Primary

MeasureTime frame
Changes in Headache Impact Test score will be assessed before and after treatmentTimepoint: 2 MONTHS- SCREENING 2 MONTHS- PATIENT ENROLLMENT 2 MONTHS- OUTCOME ASSESSMENT

Secondary

MeasureTime frame
Changes in headache frequency, duration of headache, preceding symptoms, nature of headache, assosiated symptoms, suspected triggers and relieving factors through Headache diary will be assessed before and after treatmentTimepoint: 2 MONTHS- SCREENING 2 MONTHS- PATIENT ENROLLMENT 2 MONTHS- OUTCOME ASSESSMENT

Countries

India

Contacts

Public ContactDr T Sophiya

National Institute of Siddha

drlakshmiramaswamy@gmail.com9444466880

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026